/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

E

Eng-Huat Tan

National Cancer Centre Singapore(SG)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

1

Papers

65

Citations

1

h-index

1

i10-index

Eng-Huat Tan is an academic researcher from National Cancer Centre Singapore. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & PI3K/AKT/mTOR signaling in cancer & Colorectal Cancer Treatments and Studies. The author has an h-index of 1, co-authored 1 publications.

Research Topics

Lung Cancer Treatments and Mutations PI3K/AKT/mTOR signaling in cancer Colorectal Cancer Treatments and Studies

Papers by this author

works

Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial

2016 · The Lancet Oncology · 1,143 citations

https://doi.org/10.1016/s1470-2045(16)30033-x

Keunchil Park Eng-Huat Tan Kenneth J. O’Byrne Li Zhang

Research topics

topics

Lung Cancer Treatments and Mutations

PI3K/AKT/mTOR signaling in cancer

Colorectal Cancer Treatments and Studies

Chat about Author

Papers

Chat

Click to start Chat